Several options are available to help eligible patients with the out-of-pocket costs of XOLAIR.

Find the right patient assistance option for your patient using the Patient Assistance Tool.

  • Is your patient insured?

  • Does the patient's insurance cover his or her XOLAIR?

  • Does your patient have commercial insurance?

    What does this mean?
  • Has your patient already been referred to the XOLAIR Co-pay Program and is either ineligible or no longer receiving assistance?

  • Has your patient already been referred to an independent co-pay assistance foundation and is either ineligible or no longer receiving assistance?

  • Is the patient taking XOLAIR for an FDA-approved indication?

  • Does the patient obtain XOLAIR through 1 of the participating Specialty Pharmacies or receive treatment through a buy and bill office, alternate injection center (AIC) or hospital outpatient department (HOPD)?

Your Patient Might Qualify for a Referral to the XOLAIR Co-pay Program

If eligible commercially insured patients need assistance with their drug and/or injection out-of-pocket costs, XOLAIR Access Solutions can refer them to the XOLAIR Co-pay Program.*

 

Learn More

 

*Eligibility criteria apply. Not valid for patients using federal or state government programs to pay for their medications and/or administration of their Genentech medication. Patient must be taking the Genentech medication for an FDA-approved indication. See full Terms and Conditions at XOLAIRcopay.com.

Your Patient Might Qualify for a Referral to an Independent Co-pay Assistance Foundation

For eligible patients with commercial or public health insurance, XOLAIR Access Solutions offers referrals to independent co-pay assistance foundations.*

 

Learn More

 

*Genentech and Novartis Pharmaceuticals Corporation do not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from XOLAIR Access Solutions. The foundations to which we refer patients are not exhaustive or indicative of Genentech’s or Novartis Pharmaceuticals Corporation's endorsement or financial support. There may be other foundations to support the patient's disease state.

Your Patient Might Qualify for a Referral to the Genentech Patient Foundation

The Genentech Patient Foundation provides free XOLAIR to people who don't have insurance coverage or who have financial concerns and to people who meet certain income criteria.*

 

Learn More

 

*To be eligible for free Genentech medicine from the Genentech Patient Foundation, insured patients who have coverage for their medicine should try to pursue other forms of financial assistance, if available, and meet certain income requirements. Uninsured patients and insured patients without coverage for their medicine must meet a different set of income requirements.

Does Your Patient Have Commercial Insurance?

XOLAIR Access Solutions can refer eligible patients to the XOLAIR Co-pay Program* for help with the out-of-pocket costs associated with XOLAIR and administration.

Does Your Patient Have Insurance?

If eligible publicly or commercially insured patients have difficulty paying for their co-pay, co-insurance, or other out-of-pocket costs, XOLAIR Access Solutions can refer them to an independent co-pay assistance foundation supporting their disease state.

Does Your Patient Have No Insurance or Have Financial Concerns?

The Genentech Patient Foundation helps people affected by serious medical conditions get the XOLAIR they have been prescribed. People who do not have health insurance, who have health insurance that does not cover their XOLAIR, or who can’t afford their out-of-pocket costs may get free medicine.

Is Your Patient Awaiting Coverage Determination?

With the XOLAIR Starter Program, eligible patients taking XOLAIR may receive free medicine while awaiting an insurance coverage determination.

*This XOLAIR Co-pay Program is valid ONLY for patients with commercial insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medication. Patients using Medicare, Medicaid, or any other federal or state government program to pay for their medications are not eligible.

Under the program, the patient will pay a co-pay. After reaching the maximum program benefit, the patient will be responsible for all out-of-pocket expenses.

All participants are responsible for reporting the receipt of all program benefits as required by any insurer or by law. No party may seek reimbursement for all or any part of the benefit received through this program. The program is only valid in the United States and U.S. Territories. This program is void where prohibited by law and shall follow state restrictions in relation to AB-rated generic equivalents (e.g., MA, CA) where applicable. The patient, guardian, prescriber, hospital and any other person using the program agree not to seek reimbursement for all or any part of the benefit received by the patient through the offer of this program. Genentech reserves the right to rescind, revoke or amend the program without notice at any time. Additional terms and conditions apply. Please visit XOLAIRcopay.com for the full list of Terms and Conditions.

Genentech and Novartis Pharmaceuticals Corporation do not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from XOLAIR Access Solutions. This information is provided as a resource to patients. Please note that this list is not indicative of Genentech or Novartis Pharmaceuticals Corporation’s endorsement or financial support of any particular disease area and/or foundation, nor is it exhaustive. There may be other foundations to support the patient’s disease state.

To be eligible for free XOLAIR medicine from the Genentech Patient Foundation, insured patients who have coverage for their medicine should try to pursue other forms of financial assistance, if available, and must meet certain income requirements. Uninsured patients and insured patients without coverage for their medicine must meet a different set of income requirements.

What Is XOLAIR Access Solutions?

XOLAIR Access Solutions provides reliable, effective access and reimbursement support to assist your patients and practice after XOLAIR is prescribed.

Learn how we help.

How can I find what options are available for my patient?

How can I enroll my patients?

Once enrolled in a program, how long will my patient keep receiving assistance?

What if I have questions about your programs?